Signal detection of rosuvastatin compared to other statins: Data-mining study using national health insurance claims database

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 3, 2010, Pages 238-246

  Choi, Nam Kyong ^a,b   Chang, Yoosoo ^a,c   Choi, Yu Kyong ^d   Hahn, Seokyung ^e   Park, Byung Joo ^a,b,e  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

Data mining; Health insurance claims database; Pharmacovigilance; Relative risk; Rosuvastatin

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ABDOMINAL PAIN; ACID REGURGITATION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLERGIC REACTION; ALLERGY; ALOPECIA; AMNESIA; ANAPHYLAXIS; ANEMIA; ANGIONEUROTIC EDEMA; ANOREXIA; ANXIETY; ARTHRALGIA; ARTHRITIS; ARTICLE; BACKACHE; BILIRUBIN BLOOD LEVEL; BILLING AND CLAIMS; BLURRED VISION; BRONCHITIS; CATARACT; CONSTIPATION; COUGHING; CRANIAL NEUROPATHY; CREATINE KINASE BLOOD LEVEL; DATA BASE; DATA MINING; DEPRESSION; DERMATOMYOSITIS; DIARRHEA; DIZZINESS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRY SKIN; DYSPEPSIA; DYSPNEA; EOSINOPHILIA; ERECTILE DYSFUNCTION; ERYTHEMA MULTIFORME; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGITIS; EYE IRRITATION; FACIAL NERVE PARALYSIS; FATIGUE; FATTY LIVER; FEMALE; FEVER; FLATULENCE; FLUSHING; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROENTERITIS; GLAUCOMA; GOUT; GYNECOMASTIA; HEADACHE; HEARING IMPAIRMENT; HEART ARRHYTHMIA; HEART PALPITATION; HEARTBURN; HEMATURIA; HEMOLYTIC ANEMIA; HEPATITIS; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; HYPERKINESIA; HYPERSENSITIVITY REACTION; HYPERTENSION; HYPOTENSION; IMPOTENCE; INFECTION; INFLUENZA; INSOMNIA; JAUNDICE; KIDNEY FAILURE; KOREA; LEG PAIN; LEUKOPENIA; LIBIDO; LIBIDO DISORDER; LICHEN PLANUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NECROSIS; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALAISE; MALE; MENTAL DISEASE; MIGRAINE; MUSCLE CRAMP; MUSCLE HYPERTONIA; MYALGIA; MYASTHENIA; MYOPATHY; MYOSITIS; NAIL DISEASE; NATIONAL HEALTH INSURANCE; NAUSEA; NEPHRITIS; NEURALGIA; NEUROPATHY; OBSTRUCTIVE JAUNDICE; OPHTHALMOPLEGIA; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PAIN; PANCREATITIS; PARESTHESIA; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PERIPHERAL PARALYSIS; PETECHIA; PHARYNGITIS; PHOTOSENSITIVITY; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; PURPURA; RASH; RECTUM HEMORRHAGE; RHABDOMYOLYSIS; RHEUMATIC POLYMYALGIA; RHINITIS; SIDE EFFECT; SIGNAL DETECTION; SINUSITIS; SKIN BRUISING; SKIN DISCOLORATION; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SYNCOPE; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER; TENDON CONTRACTURE; TENDON RUPTURE; THORAX PAIN; THROMBOCYTOPENIA; THYROID DISEASE; TINNITUS; TORTICOLLIS; TOXIC EPIDERMAL NECROLYSIS; TREMOR; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URTICARIA; VAGINA BLEEDING; VASCULITIS; VERTIGO; VESICULAR RASH; VOMITING; WEAKNESS; XEROSTOMIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; DATA MINING; DATABASES, FACTUAL; FEMALE; FLUOROBENZENES; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KOREA; MALE; PYRIMIDINES; RISK; SULFONAMIDES;

EID: 77649227661     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1902     Document Type: Article

References (23)

1. Hauben M, Horn S, Reich L. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions. Drug Saf 2007; 30(2): 143-155.
2. Coulter DM, Bate A, Meyboom RH, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. Br Med J 2001; 322(7296): 1207-1209.
3. Hauben M, Zhou X. Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf 2003; 26(3): 159-186.
4. DuMouchel W, Smith ET, Beasley R, Nelson H, Yang X, Fram D, Almenoff JS. Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. Clin Ther 2004; 26(7): 1092-1104.
5. Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf 2002; 25(6): 393-397.
6. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10(6): 483-486.
7. Egberts AC, Meyboom RH, van Puijenbroek EP. Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 2002; 25(6): 453-458.
8. Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 2004; 13(8): 519-523.
9. van der Heijden PG, van Puijenbroek EP, van Buuren S, van der Hofstede JW. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Stat Med 2002; 21(14): 2027-2044.
10. Norén GN, Orre R, Bate A, IR E., Duplicate detection in adverse drug reaction surveillance. Data mining and Knowledge Discovery 2007; 14(3): 305-328.
11. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005; 4(5): 929-948.
12. Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003; 12(1): 17-29.
13. Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004; 27(12): 871-881.
14. Shepherd J. Statins: putting the benefit/risk into perspective. Int J Clin Pract Suppl 2003(137): 27-33.
15. Guthrie RM, Martin DR. The safety of rosuvastatin: effects on renal and hepatic function. Expert Opin Drug Saf 2007; 6(5): 573-581.
16. Choi NK, Hahn S, Park BJ. Increase in mortality rate following coprescription of cisapride and contraindicated drugs. Ann Pharmacother 2007; 41(4): 667-673.
17. Molokhia M, McKeigue P, Curcin V, Majeed A. Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006. PLoS ONE 2008; 3(6): e2522.
18. Alsheikh-Ali AA, Ambrose MS, Kuvin JT, Karas RH., The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis. Circulation 2005; 111 23 3051-3057.
19. Choi NK, Park BJ. [Adverse drug reaction surveillance system in Korea]. J Prev Med Pub Health 2007; 40(4): 278-284.
20. van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11(1): 3-10.
21. Park BJ, Sung JH, Park KD, Seo SW, SW K. Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database. Seoul National University 2003: 19-52.
22. Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R, Ball R, Hornbuckle K,Walsh L, Yee C, Sacks ST, Yuen N, Patadia V, Blum M, Johnston M, Gerrits C, Seifert H, Lacroix K. Perspectives on the use of data mining in pharmaco-vigilance. Drug Saf 2005; 28(11): 981-1007.
23. Lindquist M, Stahl M, Bate A, Edwards IR, Meyboom RH. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf 2000; 23(6): 533-542.